Skip to main content
Azadeh Nasrazadani, MD, Oncology, Houston, TX

AzadehNasrazadaniMDPhD

Oncology Houston, TX

Breast Cancer

Medical Oncologist

Dr. Nasrazadani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Nasrazadani's full profile

Already have an account?

  • Office

    1515 Holcolme Blvd, Unit 1354
    Houston, TX 77030
    Phone+1 713-792-2817
    Fax+1 713-794-4385

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2017 - 2020
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 2015 - 2017
  • Texas Tech University Health Sciences Center Paul L. Foster School of Medicine
    Texas Tech University Health Sciences Center Paul L. Foster School of MedicineClass of 2015
  • University of Texas at Austin
    University of Texas at Austin PhD, Pharmacology, 2010

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2024 - Present
  • TX State Medical License
    TX State Medical License 2021 - 2026
  • WA State Medical License
    WA State Medical License 2023 - 2026
  • AL State Medical License
    AL State Medical License 2023 - 2025
  • AZ State Medical License
    AZ State Medical License 2023 - 2025
  • GA State Medical License
    GA State Medical License 2023 - 2025
  • LA State Medical License
    LA State Medical License 2023 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Awards, Honors, & Recognition

  • Gianni Bonadonna Breast Cancer Research Fellowship American Society of Clinical Oncology (ASCO), 2019

Publications & Presentations

PubMed

Books/Book Chapters

Abstracts/Posters

  • Mixed invasive ductal and lobular carcinoma (IDC/L) behaves similarly to invasive lobular carcinoma (ILC) with regard to neoadjuvant chemotherapy response and metastat...
    Nasrazadani A, Atkinson JM, Li Y, McAuliffe PF, Jankowitz RC, Emens LA, Tseng GC, Lee AV, Wolmark NW, Oesterreich S, Lucas PC, Cancer Res 2020;80(4 Suppl):Abstract nr P2-16-26.
  • Metastatic behavior of mixed invasive ductal lobular carcinoma (mIDC/ILC)
    Nasrazadani A, Li Y, Tseng GC, Xavier J, Lee AV, Lucas PC, Oesterreich S, Wolmark NW, Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020) 1085-1085.
  • Mixed Invasive Ductal-Lobular Carcinoma – Clinicopathological characterization and clinical outcomes
    Nasrazadani A, Li Y, Tseng G, McAuliffe P, Xavier J, Hugar S, Lee AV, Lucas P, Jankowitz R, Oesterreich S, Journal of Clinical Oncology 2019 37:15_suppl, e12531-e12531
  • Join now to see all

Lectures

  • A Current Data on the Reduction in Risk of Developing New Brain Lesions in HER2+ MBC: What Differentiates Tucatinib From Other TKIs? 
    6/11/2021
  • Dentin Matrix Protein 1 and C-Jun N-terminal Kinase: Potential Players in Breast Cancer Mediated Bone Metastasis 
    GCSOT Annual Meeting 2007, College Station, TX

Other

  • Accuracy of Ki-67 with Recurrence Score and Recurrence Score -Pathology - Clinical Assessment in Early Stage Breast Cancer 
    A Nasrazadani, A Dwivedi, S Otoukesh, O Padilla, A Alvarado, LA Sanchez, A Tfayli, and Z Nahleh, Hematol Oncol. 2014;1(3): 6.
  • Statins and Endocrine Resistance in Breast Cancer 
    Tara Hyder, Juan Luis Gomez Marti, Azadeh Nasrazadani, Adam M. Brufsky, Cancer Drug Resist 2021;4
    https://cdrjournal.com/article/view/3885
    1/25/2021

Authored Content

  • Margetuximab improves PFS in HER2-positive metastatic breast cancerJune 2019
  • Protocol for Immunohistochemistry on Mouse SpineOctober 2007

Press Mentions

  • When Tumors Collide: Analysis of Mixed-Type Breast Cancer Reveals Complexity
    When Tumors Collide: Analysis of Mixed-Type Breast Cancer Reveals ComplexityJuly 23rd, 2024
  • New Treatments for Metastatic Breast Cancer
    New Treatments for Metastatic Breast CancerDecember 20th, 2022
  • Breast Cancer Survivor: ‘MD Anderson Is a Healing Mecca’
    Breast Cancer Survivor: ‘MD Anderson Is a Healing Mecca’July 27th, 2023

Grant Support

  • Magee Women's Cancer Research & Education Funding in MBC ResearchMagee Women’s Research Institute and the Hillman Cancer Center2021–2022
  • Gianni Bonadonna Breast Cancer Research FellowshipConquer Cancer Foundation of the American Society of Clinical Oncology2019–2020
  • DoD predoctoral grantDepartment of Defense Breast Cancer Research Program2008–2011

Committees

  • Board Member, One Day to Remember 2022 - Present

Professional Memberships